P1360: CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE
Main Authors: | Memnon Lysandrou, Dionysia Kefala, Panayiota Christofi, Penelope Georgia Papagianni, Antonis Mingos, Chryso Pieridou, Elisavet Vlachonikola, Maria Kyriakou, Alexandra Lydia Chatzidaniil, Nikolaos Savvopoulos, Anastasia Papadopoulou, Anastasia Chatzidimitriou, Paul Costeas, Evangelia Yannaki, Alexandros Spyridonidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972328.41871.bb |
Similar Items
-
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses
by: Memnon Lysandrou, et al.
Published: (2023-09-01) -
Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor
by: Memnon Lysandrou, et al.
Published: (2023-05-01) -
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
by: Maria Alvanou, et al.
Published: (2023-03-01) -
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
by: Elisavet Vlachonikola, et al.
Published: (2021-06-01) -
Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
by: Panayiota Christofi, et al.
Published: (2023-12-01)